Skip to main content

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

Superinvestors holding URGN, Q2 2026

1 superinvestor reports holding UroGen Pharma Ltd. on Form 13F, worth $3.74M in total. Weight is UroGen Pharma Ltd.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding URGN in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
ARK InvestCathie Wood<0.1%101,508$3.74MReduced−12.1%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of URGN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−12.1%)
  2. Q1 2026

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−4.9%)
  3. Q4 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−4.1%)
  4. Q3 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−23.7%)
  5. Q2 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−10.6%)
  6. Q1 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+32.6%)
  7. Q4 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+15.2%)
  8. Q3 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−19.9%)
  9. Q2 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+3.7%)
  10. Q1 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−9.4%)
  11. Q4 2023

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−25.0%)
  12. Q3 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+6.6%)
  13. Q2 2023

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−25.4%)
  14. Q1 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+37.5%)
  15. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−30.1%)
  16. Q3 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−6.8%)
  17. Q2 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−9.4%)
  18. Q1 2022

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+78.8%)
  19. Q4 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−23.6%)
  20. Q3 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−22.8%)
  21. Q2 2021

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+8.4%)